Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers
about
Next-Generation Sequencing in Post-mortem Genetic Testing of Young Sudden Cardiac Death CasesHighlights of the year in JACC 2012Clinical and Mechanistic Insights Into theĀ Genetics of CardiomyopathyImproving the appropriateness of sudden arrhythmic death primary prevention by implantable cardioverter-defibrillator therapy in patients with low left ventricular ejection fraction. Point of view2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theGenotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals.[Ventricular tachycardia : Treatment and prognostic significance].Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life-Threatening Arrhythmias.The Genetic Challenges and Opportunities in Advanced Heart FailureThe BAG3 gene variants in Polish patients with dilated cardiomyopathy: four novel mutations and a genotype-phenotype correlation.Mitogen-activated protein kinase kinase 1/2 inhibition and angiotensin II converting inhibition in mice with cardiomyopathy caused by lamin A/C gene mutation.Stratification of the risk of sudden death in nonischemic heart failure.LMNA mutations in Polish patients with dilated cardiomyopathy: prevalence, clinical characteristics, and in vitro studiesGENETIC CAUSES OF DILATED CARDIOMYOPATHY.Genetics and heart failure: a concise guide for the clinicianFamilial Dilated Cardiomyopathy Caused by a Novel Frameshift in the BAG3 Gene.Genetic mutations and mechanisms in dilated cardiomyopathyA case of Lamin C gene-mutation with preserved systolic function and ventricular dysrrhythmia.Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy.Diagnosis, prevalence, and screening of familial dilated cardiomyopathy.Natural History of Dilated Cardiomyopathy in ChildrenPoor prognosis of rare sarcomeric gene variants in patients with dilated cardiomyopathyGenetics and genetic testing of dilated cardiomyopathy: a new perspective.Clinical disease presentation and ECG characteristics of LMNA mutation carriersGenetics and genomics of dilated cardiomyopathy and systolic heart failure.The Year in Cardiology 2012: arrhythmia and pacing.Genetic and clinical characteristics of skeletal and cardiac muscle in patients with lamin A/C gene mutations.Advances in basic and clinical research in laminopathies.Genetic testing for inherited cardiac disease.Genetics in dilated cardiomyopathy.Almanac 2014: cardiomyopathies.The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases.Role of nuclear Lamin A/C in cardiomyocyte functions.Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases.Current applications of biomarkers in cardiomyopathies.Nomenclature and systems of classification for cardiomyopathy in children.Dilated cardiomyopathy produced by lamin A/C gene mutations.Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future.Precision medicine approach to genetic cardiomyopathy.The MOGE(S) classification : A TNM-like classification for cardiomyopathies.
P2860
Q26745883-5914DF5C-BEFC-40D5-94ED-8CCE6EE839F7Q26865608-BDCEF33D-A4A7-40E9-8E33-9910E27B6090Q28075470-50E474D9-7C2C-4BBB-97EC-1FF32134487CQ28079620-C89DBD88-A893-478A-9745-63FA91784905Q28087002-6175B2B6-1DE2-45A7-987F-D2911F97AE41Q30248233-2145D59B-5134-4E01-8A26-9ACF2CF3BB4AQ33163466-00B9EA24-1A40-485E-95BF-732666164838Q33166353-18210708-D130-4589-A37E-C94EC35CD572Q33653498-B594490E-CBC0-42F6-B18C-51870BB86438Q33927632-60C89E83-EAE6-4DA6-8D5C-1D266309AD0AQ34289378-147E65B3-B50F-4E4B-99B8-E6507932691CQ34387880-10BD993F-57CC-48EE-A7A7-86F6DAF90774Q34736236-90B2DF92-DBBC-4A64-B90E-0DF7044CC054Q34881335-C75DCAA8-1EDC-45C8-9211-222A978BB718Q35139937-F915B882-C124-4AD7-93C9-24D93E2E7C87Q36071394-3F75CFE9-608B-4EB8-94DA-A8322F0F59B8Q36497170-928BF989-0F8A-4D1A-8129-7FABD8C80E0CQ36671762-0C6D42FF-7599-4B2D-A4B0-BE7B3BB5D8A4Q36975852-79B93FF3-B70B-4921-BA00-B7D78E293E1EQ37183864-24BAA04F-2D90-4A68-9E19-DE90063F74DEQ37240681-1079FF67-49BD-4748-8BC0-B55DE519291BQ37397192-755752DC-977C-4F1E-97A3-572AFF83C2BFQ37594505-BCA7C872-45B9-4FFC-B58C-8E123FD40472Q37598892-07D26725-8296-4DBD-9FAA-EC4DE0DD3E5CQ37661546-6A2B7513-4366-42A4-A7CF-C87476362407Q38071285-3286BEBD-EE84-4FEC-B505-5A30234A48C6Q38085610-499A970D-28FF-4D36-8A5B-3646CFBC0B2AQ38121536-9EC7C488-FDC7-4C33-86AD-77ADCD08923EQ38125385-D107EAEC-3F6F-4785-9944-67D3E23C2891Q38125766-A5D20C2F-874D-4943-96C4-41847BA97795Q38193960-20B16CC7-66D1-4058-8515-5FA53612C19BQ38197734-78491124-76B3-40BA-B3DC-63FF49058035Q38233240-2A4AD21A-2AD0-4F7F-8AF7-CF4CF443CC70Q38418005-A08A06B3-DCC8-4951-9553-F14B7E9B79E8Q38536678-141DC4CD-0308-43CD-936A-0C45204E6544Q38588152-14CD7C52-6575-45E9-A2F0-AEADFCE0D935Q38623197-149E24F9-D7EE-4120-9EF4-A57E7113F343Q38659406-E86C83DE-1689-4655-BA8B-DE5DBFCA6680Q38666336-17AC6103-BDD9-44A4-8FC1-B5695EDED80FQ38711261-AA0EE83F-1A5F-45BD-A0AB-D60E276B99D5
P2860
Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers
description
im Januar 2012 verƶffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 January 2012
@en
wetenschappelijk artikel
@nl
Š½Š°ŃŠŗŠ¾Š²Š° ŃŃŠ°ŃŃŃ, Š¾ŠæŃŠ±Š»ŃŠŗŠ¾Š²Š°Š½Š° Š² ŃŃŃŠ½Ń 2012
@uk
name
Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers
@en
Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers
@nl
type
label
Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers
@en
Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers
@nl
prefLabel
Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers
@en
Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers
@nl
P2093
P50
P1476
Risk factors for malignant ven ...... rriers a European cohort study
@en
P2093
Aeilko H Zwinderman
Andrea Pilotto
Anneke J van der Kooi
Camilla Rowland
Ingrid A W van Rijsingen
J Peter van Tintelen
Johanna F Hermans-van Ast
Maarten P van den Berg
Michele Pasotti
Perry M Elliott
P304
P356
10.1016/J.JACC.2011.08.078
P407
P577
2012-01-01T00:00:00Z